70
Views
30
CrossRef citations to date
0
Altmetric
Miscellaneous

Therapeutic potential of PKC inhibitors in painful diabetic neuropathy

Pages 1653-1664 | Published online: 24 Feb 2005

Bibliography

  • NISHIZUKA Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. (1995) 9(7):484–496.
  • WAY KJ, CHOU E, KING GL: Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends PharmacoL Sci. (2000) 21(5):181–187.
  • KRAMER HK, SIMON EJ: Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC. Neuracliern. (1999) 72(2):594–604.
  • NARITA M, MIZOGUCHI H, KAMPINE JP, TSENG LF: Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse. Br PharmacoL (1996) 118(7):1829–1835.
  • LAN JY, SKEBERDIS VA, JOVER T et al.: Protein kinase C modulates NMDA receptor trafficking and gating. Nat. NeuroscL (2001) 4(4)382–390.
  • ZHENG X, ZHANG L, WANG AP BENNETT MV, ZUKIN RS: Protein kinase C potentiation of N-methyl-D-aspartate receptor activity is not mediated by phosphorylation of N-methyl-D-aspartate receptor subunits. Proc. Natl. Acad. Li. US A (1999) 96(26):15262–15267.
  • SMITH FL, LOHMANN AB, DEWEY WL: Involvement of phospholipid signal transduction pathways in morphine tolerance in mice. Br j. PharmacoL (1999) 128(1):220–226.
  • TOULLEC D, PIANETTI E COSTE H et al.: The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. j. Biol. Chem. (1991) 266(24):15771–15781.
  • GOPALAKRISHNA R, CHEN ZH, GUNDIMEDA U: Irreversible oxidative inactivation of protein kinase C by photosensitive inhibitor calphostin C. FEBS Lett. (1992) 314(2):149–154.
  • NARITA M, NARITA M, MIZOGUCHI H, TSENG LF: Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse. Eur.j PharmacoL (1995) 280(2):R1–3.
  • BARG J, BELCHEVA MM, COSCIA CJ: Evidence for the implication of phosphoinositol signal transduction in mu- opioid inhibition of DNA synthesis. j.Neurochem. (1992) 59(3):1145–1152.
  • GRANADOS-SOTO V, KALCHEVA I, HUA X, NEWTON A, YAKSH TL: Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion. Pain (2000) 85(3):395–404.
  • NARITA M, MIZOGUCHI H, NARITA M, NAGASE H, SUZUKI T, TSENG LF: Involvement of spinal PKCy in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of 0-A1a2,N-MePhe4,Gly-01(5)1enkephalin. j Neurosci. (2001) 21(11):3715–3720.
  • WILKINSON SE, PARKER PJ, NIXON JS: Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem. j. (1993) 294\(Pt 2)335–337.
  • KOBAYASHI E, NAKANO H, MORIMOTO M, TAMAOKI T: Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. (1989) 159(2):548–553.
  • PORTENOY RK: Cancer pain: pathophysiology and syndromes. Lancet (1992) 339(8800):1026–1031.
  • CHERNY NI, THALER HT, FRIEDLANDER-KLAR H etal.: Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies. Neurology (1994) 44(5):857–861.
  • MCQUAY HJ: Opioid use in chronic pain. Acta. ArraesthesioL Scam/. (1997) 41(1 Pt 2):175–183.
  • CODERRE TJ, GRIMES RW, MELZACK R: Deafferentation and chronic pain in animals: an evaluation of evidence suggesting autotomy is related to pain. Pain (1986) 26(1):61–84.
  • BENNETT GJ, XIE YK: A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain (1988) 33(1):87–107.
  • SELTZER Z, DUBNER R, SHIR Y: A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain (1990) 43(2):205–218.
  • KIM SH, CHUNG JM: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain (1992) 50(3):355–363.
  • TAKASAKI I, AND OH T, NITTA M et al.: Pharmacological and immunohistochemical characterization of a mouse model of acute herpetic pain. Jpri. PharmacoL (2000) 83(4):319–326.
  • HONORE P, ROGERS SD, SCHWEI MJ et al.: Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience (2000) 98(3):585–598.
  • KAMEI J, IWAMOTO Y, SUZUKI T et al.: Suppression of hyperalgesia in streptozotocin-induced diabetic mice by a lipopolysaccharide from Pantoea agglomerans. Biol. Pharm. Bull. (1994) 17(5):632–634.
  • KAMEI J, SODEYAMA M, OHSAWA M, KIMURA M, TANAKA S: Modulation by serum glucose levels on morphine-induced antinociceptive effect in C5713L/KsJ-db/clb mice. Life Sci. (1998) 62(1):PL1–6.
  • AL-GHOUL WM, VOLSI GL, WEINBERG RJ, RUSTIONI A: Glutamate immunocytochemistry in the dorsal horn after injury or stimulation of the sciatic nerve of rats. Brain Res. Bull. (1993) 30(3–4)453–459.
  • FUNDYTUS ME, YASHPAL K, CHABOT JG et al.: Knockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in rats. Br j. PharmacoL (2001) 132(1):354–367.
  • ISAEV D, GERBER G, PARK SK, CHUNG JM, RANDIK M: Facilitation of NMDA-induced currents and Ca2+ transients in the rat substantia gelatinosa neurons after ligation of L5-L6 spinal nerves. Neuroreport (2000) 11(18):4055–4061.
  • FISHER K, FUNDYTUS ME, CAHILL CM, CODERRE TJ: Intrathecal administration of the mGluR compound, (S)-4CPG, attenuates hyperalgesia and allodynia associated with sciatic nerve constriction injury in rats. Pain (1998) 77(1):59–66.
  • MAO J, PRICE DD, MAYER DJ: Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved inmorphine tolerance and neuropathic pain. Pain (1995) 61(3):353–364.
  • BACKONJA M, ARNDT G, GOMBAR KA, CHECK B, ZIMMERIVIANN M: Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain (1994) 56(1):51–57.
  • CRUCE WL, LOVELL JA, CRISP T, STUESSE SL: Effect of aging on the substance P receptor, NK-1, in the spinal cord of rats with peripheral nerve injury. Somatosens. Mot. Res. (2001) 18(1):66–75.
  • URBAN L, DRAY A: Synaptic activation of dorsal horn neurons by selective C-fibre excitation with capsaicin in the mouse spinal cord in vitro. Neuroscience (1992) 47(3)693–702.
  • MANSIKKA H, SHETH RN, DEVRIES C, LEE H, WINCHURCH R, RAJA SN: Nerve injury-induced mechanical but not thermal hyperalgesia is attenuated in neurokinin-1 receptor knockout mice. Exp. Neural. (2000) 162(2): 343–349.
  • OHSAWA M, KAMEI J: Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice. Eur. j Pharmacol. (1999) 372(3):221–228.
  • CODERRE TJ: Contribution of protein kinase C to central sensitization and persistent painfollowing tissue injury. Neurosci. Lett. (1992) 140(2):181–184.
  • GERBER G, KANGRGA I, RYU PD, LAREW JS, RANDIC M: Multiple effects of phorbol esters in the rat spinal dorsal horn. j Neurosci. (1989) 9(10):3606–3617.
  • CHEN L, HUANG LY: Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron (1991) 7(2):319–326.
  • MAO J, PRICE DD, MAYER DJ, HAYES RL: Pain-related increases in spinal cord membrane-bound protein kinase C following peripheral nerve injury. Brain Res. (1992) 588(1):144–149.
  • MARTIN WJ, LIU H, WANG H, MALMBERG AB, BASBAUM Al: Inflammation-induced up-regulation of protein kinase Cgamma immunoreactivity in rat spinal cord correlates with enhanced nociceptive processing. Neuroscience (1999) 88(4):1267–1274.
  • VACCARINO F, GUIDOTTI A, COSTA E: Ganglioside inhibition of glutamate-mediated protein kinase C translocation in primary cultures of cerebellar neurons. Proc. Natl. Acad. Li. USA (1987) 84(23):8707–8711.
  • HAYES RL, MAO J, PRICE DD et al.: Pretreatment with gangliosides reduces abnormal nociceptive responses associated with a rodent peripheral mononeuropathy. Pain (1992) 48(3):391–396.
  • MALMBERG AB, CHEN C, TONEGAWA S, BASBAUM Al: Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. Science (1997) 278(5336):279–283.
  • MALMBERG AB, BRANDON EP, IDZERDA RL, LIU H, MCKNIGHT GS, BASBAUM Al: Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the Type I regulatory subunit of cAMP-dependent protein kinase. Neurosci. (1997) 17(19):7462–7470.
  • MALMBERG AB, BASBAUM Al: Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain (1998) 76(1-2):215–222.
  • GREENE DA, SIMA AAF, STEVENS MJ,FELDMAN EL, LATTIMER SA: Complication: neuropathy, pathogenic considerations. Diabetes Care (1992) 15:1902–1925.
  • KOYA D, KING GL: Protein kinase C activation and the development of diabetic complications. Diabetes (1998) 47:859–866.
  • INOGUCHI T, BATTAN R, HANDLER E, SPORTSMAN JR, HEATH W, KING GL: Preferential elevation of protein kinase C isoform pll and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc. Nati Acad. Sci. USA (1992) 89:11059–11063.
  • INOGUCHI T, XIA P, KUNISAKI M, HIGASHI S, FEENER EP, KING GL: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am. I Physiol. (1994) 267:E369–E379.
  • ISHII H, JIROUSEK MR, KOYA D etal.: Amelioration of vascular dysfunction in diabetic rats by an oral PKCP inhibitor. Science (1996) 272:728–731.
  • KOYA D, JIROUSEK MR, LIN Y- W, ISHII H, KUBOKI K, KING GL: Characterization of protein kinase CP isoform activation on the gene expression of transforming growth factor-b extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. j Clin. Invest. (1997) 100:115–126.
  • TESFAYE S, MALIK R, WARD JD: Vascular factors in diabetic neuropathy. Diabetologia (1994) 37:847–854.
  • CAMERON NE, COTTER MA: Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes (1997) 46\(Suppl. 2):531–537
  • CAMERON NE, COTTER MA: The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab. Rev. (1994) 10:189–224.
  • MAXFIELD EK, LOVE A, COTTER MA, CAMERON NE: Nerve function and regeneration in diabetic rats: effects of ZD-7155, an AT1 receptor antagonist. Am. Physiol. (1995) 69:E530–E537.
  • HOTTA N, KOH N, SAKAKIBARA F et al.: Effects of beraprost sodium and insulin on the electroretinogram, nerve conduction, and nerve blood flow in rats with streptozotocin-induced diabetes. Diabetes (1996) 45:361–366.
  • HOTTA N, KOH N, SAKAKIBARA F et al.: Prevention of abnormalities in motor nerve conduction and nerve blood-flow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic rats. Prostaglandins (1995) 49:339–349.
  • HOTTA N, KOH N, SAKAKIBARA F, NAKAMURA J et al.: Nerve function and blood flow in Otsuka Long-Evans Tokushima Fatty rats with sucrose feeding: effect of an anticoagulant. Eur. j Pharmacol. (1996) 313:201–209.
  • SHIMAMOTO Y, SHIMAMOTO H, KWAN C, DANIEL EE: Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle. Am. J Physiol. (1993) 264:H1300–H1306.
  • COHEN RA: Dysfunction of vascular endothelium in diabetes mellitus. Circulation (1993) 87(Suppl. V):67–76.
  • NAKAMURA J, KATO K, HAMADA Y et al.: A protein kinase C-3-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Diabetes (1999) 48:2090–2095.
  • GREENE DA, LATTIMER-GREENE SA, SIMA AAF: Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism. Crit. Rev. Neurobiol. (1989) 5:143–219.
  • KIM J, RUSHOVICH EH, THOMAS TP, UEDA T, AGRANOFF BW, GREENE DA: Diminished specific activity of cytosolic protein kinase C in sciatic nerves of streptozocin-induced diabetic rats and its correction by dietary myo-inositol. Diabetes (1991) 40:1545–1554.
  • MATHEW J, BIANCHI R, MCLEAN WG et al: Phosphoinositide metabolism: Na, K-ATPase and protein kinase C are altered in peripheral nerve from Zucker diabetic fatty rats (ZDF/Gmi-fa). Neurosci. Res. Commun. (1997) 20:21–30.
  • KOWLURU RA, JIROUSEK MR, STRAMM L, FARID N, ENGERMAN RL, KERN TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. V Relationship between protein kinase C and ATPases. Diabetes (1998) 47:464–469.
  • BORGHINI I, ANIA-LAHUERTA A, REGAZZI R et al: a, 13I, pi, 8, and E protein kinase C isoforms and compound activity in the sciatic nerve of normal and diabetic rats. j Neurochem. (1994) 62:686–696.
  • ROBERTS RE, MCLEAN WG: Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats. Brain. Res. (1997) 754: 147–156.
  • YONEMURA D, AOKI T, TSUZUKI K: Electroretinogram in diabetic retinopathy. Arch. Oplithalmal. (1962) 68:49–54.
  • ALGVER P: Clinical studies on the oscillatory potentials of the human electroretinogram with special reference to the scotopic 13-wave. Acta Oplithalmal. (1968) 46:993–1024.
  • HOTTA N, KAKUTA H, FUKASAWA H et al.: Effect of niceritrol on streptozotocin-induced diabetic neuropathy in rats. Diabetes (1992) 41:587–591.
  • GUY RJC, CLARK CA, MALCOLM PN, WATKINS PJ: Evaluation of thermal and vibration sensation in diabetic neuropathy. Diabetologia (1985) 28:131–137.
  • LE QUESNE PM, FOWLER CJ: A study of pain threshold in diabetics with neuropathic foot lesions. j Neural Neurosurg. Psychiat. (1986) 49:1191–1194.
  • WATKINS J: Natural history of the diabetic neuropathy. DIM, New series 77(1990) 284:1209–1218.
  • ZIEGLER D, MAYER E WIEFELS K, GRIES FA: Assessment of small and large fiber function in long-term Type 1 (insulin-dependent) diabetic patients with and without painful neuropathy. Pain (1988) 34(1):1–10.
  • MORLEY GK, MOORADIAN AK, LEVINE AD, MORLEY JE: Mechanisms of pain in diabetic peripheral neuropathy: Effect of glucose on pain perception in humans. Am. j Med. (1984) 77:79–82.
  • BAYS HE, PFEIFER M: Diabetes mellitus. Peripheral diabetic neuropathy. Med. Clin. N. Am. (1988) 72:1439–1464.
  • FORMAN LJ, LEWIS SEM, VASILENKO P: Streptozotocin diabetes alters immunoreactive 13-endorphin levels and pain perception after 8 weeks in female rats. Diabetes (1986) 35:1309–1313.
  • LEE JH, MCCARTY RC: Glycemic control of pain threshold in diabetic and control rats. Physial Behav. (1990) 47:225–230.
  • KAMEI J, OHHASHI Y, AOKI T, KASUYA Y: Streptozotocin-induced diabetes in mice reduces the nociceptive threshold, as recognized after application of noxious mechanical stimuli but not for thermal stimuli. Pharmacy]. Biochem. Behav. (1991) 39:541–544.
  • COUTERIX C, ESCHALIER A, LAVARENNE J: Streptozotocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain (1993) 53:81–88.
  • GREENE DA, LATTIMER SA, SIMA AA: Sorbitol, phosphoinositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl. I Med. (1987) 316:599–605.
  • BITAR M, KOULU M, RAPOPORT SI, LINNOKA M: Diabetes-induced alteration in brain monoamine metabolism in rats. Pharmacy]. Exp. Ther. (1985) 236:432–437.
  • CHU PC, LIN MT, LEU SY: Alterations in physiological functions and in brain monoamine content in STZ-diabetic rats. Diabetes (1986) 35:481–485.
  • TRULSON ME, JACOBY JH, MACKENZIE RG: Streptozotocin-induced diabetes reduces brain serotonin synthesis in rats. j Neurochem. (1986) 46:1068–1072.
  • MASIELLO P, BALESTRERI E, BACCIOLA D, BERGAMINI E: Influence of experimental diabetes on brain levels of monoamine neurotransmitters and their precursor amino acids during tryptophan loading. Acta Diabetal Lat. (1987) 24:43–50.
  • LACKOVIC Z, SALKOVIC M: Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction. Life Li. (1990) 46(1):49–52.
  • BELLUSH LL, REID SG: Altered behaviorand neurochemistry during short-term insulin withdrawal in streptozotocin-induced diabetic rats. Diabetes (1991) 40:217–222.
  • CRAVEN PA, DE RUBERTIS FR: Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. j Clin. Invest. (1989) 83:1667–1675.
  • KING GL, JOHNSON S, WU G: Possible growth modulators involved in the pathogenesis of diabetic proliferative retinopathy. In: Growth Factors in Health and Diseases. Westermark B, Betscholtz C, Hokfelt T (Eds.), Elsevier, Amsterdam, The Netherlands, (1990):303–317.
  • TANAKA A, KASHIWAGI Y, OGAWA T et al.: Effect of verapamil on cardiac protein kinase C activity in diabetic rats. Eur. Pharmacy]. (1991) 200:353–356.
  • SHIBA T, INOGUCHI T, SPORTSMAN R, HEALTH W, BURSELL SE, KING GL: Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am. j Physial (1993) 265:E787–E793.
  • WOLF BA, WILLIAMSON JR, EASOM RA, CHANG K, SHERMAN WR, TURK J: Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. I Clin. Invest. (1990) 98:31–38.
  • OHSAWA M, KAMEI J: Possible involvement of protein kinase C in the attenuation of DAMGO-induced antinociception in diabetic mice. Eur. Pharmacy]. (1997) 339:27–31.
  • GOETTL,VM, LARSON, DL, PORTOGHESE, PS, LARSON AA: Inhibition of substance P release from spinal cord tissue after pretreatment with capsaicin in adult mice. Pain (1997) 71:271–278.
  • KAMEI J, OGAWA Y, OHHASHI Y, KASUYA Y: Alterations in the potassium-evoked release of substance P from the spinal cord of streptozotocin-induced diabetic rats in vitro. Gen. Pharmacy]. (1991) 22:1093–1096.
  • CATTERALL WA: Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. Ann. Rev. Pharmacy]. Tarim]. (1980) 20:15–43.
  • HOEHN K, WATSON TW, MACVICAR BA: A novel tetrodotoxin-insensitive, slow sodium current in striatal and hippocampal neurons. Neuron (1993) 10:543–552.
  • YOSHIDA S: Tetrodotoxin-resistant sodium channels. Cell. Mal Neurobial. (1994) 14:227-244. 1663
  • COTTON JF, WELSH MJ: Covalent modification of the regulatory domain irreversible stimulates cystic fibrosis transmembrane conductance regulator. _J. Biol. Chem. (1997) 272:25617–25622.
  • KOSTYUK PG, VESELOVSKY NS, TSYNDRENKO YA: Ionic currents in the somatic membrane of rat dorsal root ganglion neurons: I. Sodium currents. Neuroscience (1981) 6:2423–2430.
  • MCLEAN MJ, BENNETT PB, THOMAS RM: Subtypes of dorsal root ganglion neurons based on different inward currents as measured by whole-cell voltage clamp. Mal Cell. Biochem. (1988) 80:95–107.
  • OGATA N, TATEBAYASHI H: Kinetic analysis of two types of Na+ channels in rat dorsal root ganglia. j Physiol (London) (1993) 466:9–37.
  • AKOPIAN AN, SIVILOTTI L, WOOD JN: A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature (1996) 379:257–262.
  • ARBUCKLE JB, DOCHERTY RJ: Expression of tetrodotoxin-resistant sodium channels in capsaicin-sensitive dorsal root ganglion neurons of adult rats. Neurosci. Lett. (1995) 185:70–73.
  • NOVAKOVIC SD, TZOUMAKA E, MCGIVERN JG et al.: Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions. j Neurosci. (1998) 18:2174–2187.
  • RABERT DK, KOCH BD, ILNICKA Met al.: A tetrodotoxin-resistant voltage-gated sodium channel from human dorsal root ganglia, hPN3/SCN10A. Pain (1998) 78:107–114.
  • SANGAMESWARAN L, DELGADO SG, FISH LM et al: Structure and function of a novel voltage-gated tetrodotoxin-resistant sodium channel specific to sensory neurons. Biol. Chem. (1996) 271:5953–5956.
  • TATE S, BENN S, HICK C etal.: Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons. Nature NeuroscL (1998) 1:653–655.
  • PORECCA F, LAI J, BIAN D et al: Comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/5N52, in rat model of chronic pain. Proc. Natl. Acad. Li. USA (1999) 96:7640–7644.
  • CARDENAS CG, DEL MAR LP, COOPER BY, SCROGGS RS: 5-HT4 receptors couple positively to tetrodotoxin-insensitive sodium channels in a subpopulation of capsaicin-sensitive rat sensory neurons. j Neurosci. (1997) 17: 7181–7189.
  • ENGLAND S, BEVAN S, DOCHERTY RJ: PGE2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. j Physiol. (London) (1996) 495:429–440.
  • GOLD MS, REICHLING DB, SHUSTER MJ, LEVINE JD: Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc. Natl. Acad. Sci. USA (1996) 93:1108–1112.
  • AKOPIAN AN, SOUSLOVA V, ENGLAND S et al: The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nature Neurosci. (1999) 2:541–548.
  • THIO CL, SONTHEIMER H: Differential modulation of TTX-sensitive and TTX-resistant Na+ channels in spinal cord astrocytes following activation of protein kinase C. j Neurosci. (1993) 13:4889–4897.
  • GOLD MS, LEVINE JD, CORREA AM: Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro Neurosci. (1998) 18:10345–10355.
  • KHASAR SG, LIN YH, MARTIN A et aL: A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron (1990) 24:253–260.
  • HIRADE M, YASUDA H, OMATSU-KANBE M, KIKKAWA R, KITASATO H: Tetrodotoxin-resistant sodium channels of dorsal root ganglion neurons are readily activated in diabetic rats. Neuroscience (1999) 90(3):933–939.
  • CATERINA MJ, ROSEN TA, TOMINAGA M, BRAKED, JULIUS D: A capsaicin-receptor homologue with a high threshold for noxious heat. Nature (1999) 398:436–441.
  • CATERINA MJ, SCHUMACHER MS, TOMINAGA M, ROSEN TA, LEVINE JD, JULIUS D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (1997) 389:816–824.
  • HELLIWELL RJ, MCLATCHIE LM, CLARKE M, WINTER J, BEVAN S, MCINTYRE P: Capsaicin sensitivity is associated with the expression of the vanilloid (capsaicin) receptor (VRI) mRNA in adult rat sensory ganglia. Neurosci. Lett. (1998) 250:177–180.
  • TOMINAGA M, CATERINA MJ, MALMBERG AB etal.: The cloned capsaicin receptor integrates multiple pain-modulating stimuli. Neuron (1998) 21:531–543.
  • DE CASTRO F, SILOS-SANTIAGO I, LOPEZ DE ARMENTIA M, BARBACID M, BELMONTE C: Corneal innervation and sensitivity to noxious stimuli in trItA knockout mice. Eur. j Neurosci. (1998) 10:146–152.
  • GARCIA-HIRSCHFELD J, LOPEZ-BRIONES LG, BELMONTE C, VALDEOLMILLOS M: Intracellular free calcium responses to protons and capsaicin in cultured trigeminal neurons. Neuroscience (1995) 67:235–243.
  • STEEN KH, REEH PW, ANTON F, HANDWERKER HO: Protons selectively induce lasting excitation and sensitization to mechanical stimulation of nociceptors in rat skin in vitro. j Neurosci. (1992) 12:86–95.
  • KAMEI J, ZUSHIDA K, MORITA K, SASAKI M, TANAKA S: Role of vanilloid VR1 receptor in thermal allodynia and hyperalgesia in diabetic mice. Eur. Pharmacol (2001) 422:83–86.
  • PREMKUMAR LS, AHERN GP: Induction of vanilloid receptor channel activity by protein kinase C. Nature (2000) 408:985–990.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.